Compare LADR & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LADR | TLRY |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | 2014 | 2018 |
| Metric | LADR | TLRY |
|---|---|---|
| Price | $11.39 | $11.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $12.75 | ★ $150.00 |
| AVG Volume (30 Days) | 753.4K | ★ 18.2M |
| Earning Date | 02-05-2026 | 01-09-2026 |
| Dividend Yield | ★ 8.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | $233,492,000.00 | ★ $830,766,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | $6.81 | $4.51 |
| P/E Ratio | $18.13 | ★ N/A |
| Revenue Growth | N/A | ★ 2.31 |
| 52 Week Low | $9.68 | $3.51 |
| 52 Week High | $11.92 | $23.20 |
| Indicator | LADR | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 64.01 | 69.31 |
| Support Level | $10.79 | $10.50 |
| Resistance Level | $11.48 | $15.70 |
| Average True Range (ATR) | 0.18 | 1.49 |
| MACD | 0.03 | 0.47 |
| Stochastic Oscillator | 84.06 | 50.00 |
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.